These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 27527491)

  • 1. Polymeric micelles for MCL-1 gene silencing in breast tumors following systemic administration.
    Garg SM; Falamarzian A; Vakili MR; Aliabadi HM; Uludağ H; Lavasanifar A
    Nanomedicine (Lond); 2016 Sep; 11(17):2319-39. PubMed ID: 27527491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodegradable amphiphilic poly(ethylene oxide)-block-polyesters with grafted polyamines as supramolecular nanocarriers for efficient siRNA delivery.
    Xiong XB; Uludağ H; Lavasanifar A
    Biomaterials; 2009 Jan; 30(2):242-53. PubMed ID: 18838158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Traceable PEO-poly(ester) micelles for breast cancer targeting: The effect of core structure and targeting peptide on micellar tumor accumulation.
    Garg SM; Paiva IM; Vakili MR; Soudy R; Agopsowicz K; Soleimani AH; Hitt M; Kaur K; Lavasanifar A
    Biomaterials; 2017 Nov; 144():17-29. PubMed ID: 28818703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinase 2-responsive micelle for siRNA delivery.
    Wang HX; Yang XZ; Sun CY; Mao CQ; Zhu YH; Wang J
    Biomaterials; 2014 Aug; 35(26):7622-34. PubMed ID: 24929619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virus-mimetic polymeric micelles for targeted siRNA delivery.
    Xiong XB; Uludağ H; Lavasanifar A
    Biomaterials; 2010 Aug; 31(22):5886-93. PubMed ID: 20427082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin.
    Xiong XB; Ma Z; Lai R; Lavasanifar A
    Biomaterials; 2010 Feb; 31(4):757-68. PubMed ID: 19818492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymeric micelles for the solubilization and delivery of STAT3 inhibitor cucurbitacins in solid tumors.
    Molavi O; Ma Z; Mahmud A; Alshamsan A; Samuel J; Lai R; Kwon GS; Lavasanifar A
    Int J Pharm; 2008 Jan; 347(1-2):118-27. PubMed ID: 17681440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A theranostic micelleplex co-delivering SN-38 and VEGF siRNA for colorectal cancer therapy.
    Lee SY; Yang CY; Peng CL; Wei MF; Chen KC; Yao CJ; Shieh MJ
    Biomaterials; 2016 Apr; 86():92-105. PubMed ID: 26896610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conjugation of arginine-glycine-aspartic acid peptides to poly(ethylene oxide)-b-poly(epsilon-caprolactone) micelles for enhanced intracellular drug delivery to metastatic tumor cells.
    Xiong XB; Mahmud A; Uludağ H; Lavasanifar A
    Biomacromolecules; 2007 Mar; 8(3):874-84. PubMed ID: 17315946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of siRNA pre-Exposure on Subsequent Response to siRNA Therapy.
    Aliabadi HM; Mahdipoor P; Kucharsky C; Chan N; Uludağ H
    Pharm Res; 2015 Dec; 32(12):3813-26. PubMed ID: 26129766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide modified polymeric micelles specific for breast cancer cells.
    Mathews AS; Ahmed S; Shahin M; Lavasanifar A; Kaur K
    Bioconjug Chem; 2013 Apr; 24(4):560-70. PubMed ID: 23514428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decoration of polymeric micelles with cancer-specific peptide ligands for active targeting of paclitaxel.
    Shahin M; Ahmed S; Kaur K; Lavasanifar A
    Biomaterials; 2011 Aug; 32(22):5123-33. PubMed ID: 21501865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fine tuning micellar core-forming block of poly(ethylene glycol)-block-poly(ε-caprolactone) amphiphilic copolymers based on chemical modification for the solubilization and delivery of doxorubicin.
    Yan J; Ye Z; Chen M; Liu Z; Xiao Y; Zhang Y; Zhou Y; Tan W; Lang M
    Biomacromolecules; 2011 Jul; 12(7):2562-72. PubMed ID: 21598958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic delivery of siRNA by T7 peptide modified core-shell nanoparticles for targeted therapy of breast cancer.
    Yu MZ; Pang WH; Yang T; Wang JC; Wei L; Qiu C; Wu YF; Liu WZ; Wei W; Guo XY; Zhang Q
    Eur J Pharm Sci; 2016 Sep; 92():39-48. PubMed ID: 27355138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-associating poly(ethylene oxide)-b-poly(alpha-cholesteryl carboxylate-epsilon-caprolactone) block copolymer for the solubilization of STAT-3 inhibitor cucurbitacin I.
    Mahmud A; Patel S; Molavi O; Choi P; Samuel J; Lavasanifar A
    Biomacromolecules; 2009 Mar; 10(3):471-8. PubMed ID: 19175305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymeric micelles based on poly(ethylene oxide) and α-carbon substituted poly(ɛ-caprolactone): An in vitro study on the effect of core forming block on polymeric micellar stability, biocompatibility, and immunogenicity.
    Garg SM; Vakili MR; Lavasanifar A
    Colloids Surf B Biointerfaces; 2015 Aug; 132():161-70. PubMed ID: 26037706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo safety evaluation of biodegradable self-assembled monomethyl poly (ethylene glycol)-poly (ε-caprolactone)-poly (trimethylene carbonate) micelles.
    Yang X; Cao D; Wang N; Sun L; Li L; Nie S; Wu Q; Liu X; Yi C; Gong C
    J Pharm Sci; 2014 Jan; 103(1):305-13. PubMed ID: 24282070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Traceable multifunctional micellar nanocarriers for cancer-targeted co-delivery of MDR-1 siRNA and doxorubicin.
    Xiong XB; Lavasanifar A
    ACS Nano; 2011 Jun; 5(6):5202-13. PubMed ID: 21627074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer.
    Kim SH; Jeong JH; Lee SH; Kim SW; Park TG
    J Control Release; 2008 Jul; 129(2):107-16. PubMed ID: 18486981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel self-associating poly(ethylene oxide)-b-poly(epsilon-caprolactone) based drug conjugates and nano-containers for paclitaxel delivery.
    Shahin M; Lavasanifar A
    Int J Pharm; 2010 Apr; 389(1-2):213-22. PubMed ID: 20080163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.